Skip to main content
PMC home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1952 Nov;28(11):748–765.

An Interpretation of the Significance of Influenza Virus Variation for the Development of an Effective Vaccine*

Jonas E Salk
PMCID: PMC1877218  PMID: 12987937

Full text

PDF
748

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDREWES C. H. Adventures among viruses; epidemic influenza. N Engl J Med. 1950 Feb 9;242(6):197–203. doi: 10.1056/NEJM195002092420601. [DOI] [PubMed] [Google Scholar]
  2. Francis T., Salk J. E., Quilligan J. J. Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report. Am J Public Health Nations Health. 1947 Aug;37(8):1013–1016. doi: 10.2105/ajph.37.8.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Francis T., Salk J. E., Quilligan J. J. Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report. Am J Public Health Nations Health. 1947 Aug;37(8):1013–1016. doi: 10.2105/ajph.37.8.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HILLEMAN M. R. System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc Soc Exp Biol Med. 1951 Oct;78(1):208–215. doi: 10.3181/00379727-78-19023. [DOI] [PubMed] [Google Scholar]
  5. ISAACS A., ANDREWES C. H. The spread of influenza; evidence from 1950-1951. Br Med J. 1951 Oct 20;2(4737):921–927. doi: 10.1136/bmj.2.4737.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MEIKLEJOHN G., KEMPE C. H., THALMAN W. G., LENNETTE E. H. Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic. Am J Hyg. 1952 Jan;55(1):12–21. doi: 10.1093/oxfordjournals.aje.a119500. [DOI] [PubMed] [Google Scholar]
  7. SALK J. E. A critique of serologic methods for the study of influenza viruses. Arch Gesamte Virusforsch. 1951;4(4):476–484. doi: 10.1007/BF01241167. [DOI] [PubMed] [Google Scholar]
  8. SALK J. E., BAILEY M. L., LAURENT A. M. The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion. Am J Hyg. 1952 May;55(3):439–456. doi: 10.1093/oxfordjournals.aje.a119534. [DOI] [PubMed] [Google Scholar]
  9. SALK J. E., LAURENT A. M., BAILEY M. L. Direction of research on vaccination against influenza; new studies with immunologic adjuvants. Am J Public Health Nations Health. 1951 Jun;41(6):669–677. doi: 10.2105/ajph.41.6.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SALK J. E., LAURENT A. M. The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions. J Exp Med. 1952 May 1;95(5):429–447. doi: 10.1084/jem.95.5.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SALK J. E., LEWIS L. J., YOUNGNER J. S., BENNETT B. L. The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses. Am J Hyg. 1951 Sep;54(2):157–173. doi: 10.1093/oxfordjournals.aje.a119474. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES